Results 131 to 140 of about 166,859 (297)

Use of Patient Reported Outcome Measurements Information in Clinical Practice in Spain for the Clinical Management of Psoriasis Patients—Summer Project

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Routine collection of patient perspectives about psoriasis and its treatment through patient reported outcome measurements (PROMs), alongside clinician reported outcome measurements (CROMs), may improve clinical outcomes and facilitate shared decision making.
Jaime Notario   +7 more
wiley   +1 more source

A psoriasis és annak gyógyszerészi gondozási vonatkozásai

open access: yes, 2014
A diplomamunka ismerteti a psoriasis és az arthritis psoriatica kialakulásának mechanizmusát, külső megjelenésének formáit és azok kezelési módjait.
Pazonyi, Boglárka
core  

Clinical Efficacy and Safety of Topical Roflumilast in Psoriasis: An Updated Systematic Review and Meta‐Analysis of Randomized Controlled Trials

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Traditional first‐line topical treatments for plaque psoriasis, particularly corticosteroids and vitamin D analogs, frequently have only limited efficacy for long‐term use, and present difficulties with safety and adherence. Objectives In this systematic review and meta‐analysis of randomized controlled trials (RCTs), we assessed ...
Aimal A. Khattak   +11 more
wiley   +1 more source

Evaluación de la eficacia del aloe vera 40% vs valerato betametasona 0.05% en el tratamiento de la psoriasis vulgar en los pacientes de la Fundación Ecuatoriana de Psoriasis en Quito en el año 2004

open access: yes, 2005
La Psoriasis es una enfermedad que afecta al proceso de renovación de la piel, las células se forman demasiado rápido formando escamas blancas sobre manchas rojizas, especialmente en el cuero cabelludo, codos, rodillas.
Lozada Santana, Lorena Alexandra.
core   +1 more source

ADVANCEMENT OF TREATMENT OF PSORIASIS

open access: yes
This paper explores how the treatment of psoriasis has advanced in the last century as the understanding of the pathogenesis of the disease is better understood.egységes, osztatlanáltalános ...
EYATU, ATIM ANITA
core  

JAK Inhibitors in Psoriatic–Atopic Dermatitis Overlap: A Four‑Case Series

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Overlap between psoriasis and atopic dermatitis (AD) poses diagnostic and therapeutic challenges; monoclonal antibodies targeting a single axis may improve one component while worsening the other [1]. Janus kinase (JAK) inhibitors act pleiotropically and may provide simultaneous control of psoriatic and eczematous inflammation [2].
Eleonora Bongiovanni   +6 more
wiley   +1 more source

Generalized pustular psoriasis treated with apremilast in a patient with multiple medical comorbidities

open access: yesJAAD Case Reports, 2017
Caleb Jeon, BS   +6 more
doaj   +1 more source

Targeting CLEC4E in immunosuppressive tumour‐associated macrophages via BET inhibition

open access: yesClinical and Translational Medicine
Background Immunosuppressive tumour‐associated macrophages (TAMs) represent a promising target for cancer immunotherapy; however, existing TAM‐directed therapies have shown limited clinical efficacy. C‐type lectin domain family 4 member E (CLEC4E), a pro‐
Mengting Liao   +10 more
doaj   +1 more source

Should Dermatologists Recommend Direct‐to‐Consumer App‐Based Remote Diagnostics? An Ethical Analysis

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Dermatology patients still face barriers in accessing timely specialist care. As direct‐to‐consumer (DTC) apps for remote dermatological diagnostics proliferate, guidance is lacking. While promising efficiency and efficacy, their clinical—and ethical—legitimacy is not yet well established.
Sonja Mathes   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy